Exhibit 11(a) - Joint Meeting of Arthritis Advisory Committee Tanenzumab Advisory Materials Briefing Document (Mar. 24-25 2021)
NonrulemakingSupporting & Related MaterialFDA-2026-P-6249-0018
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 3, 2026
- Agency
- Food and Drug Administration (FDA)